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Abstract
Purpose: Beside its efficacy in cancer treatment, radiotherapy induces degeneration of healthy tissues within the irradiated
area. The aim of this study was to analyze the variations of proinflammatory (IL-1a, IL-2, IL-6, TNF-a, IFN-c), profibrotic (TGF-
b1), proangiogneic (VEGF) and stem cell mobilizing (GM-CSF) cytokines and growth factors in an animal model of radiation-
induced tissue degeneration.
Materials and Methods: 24 rats were irradiated unilaterally on the hindlimb at a monodose of 30 Gy. Six weeks (n=8), 6
months (n=8) and 1 year (n=8) after irradiation the mediators expression in skin and muscle were analyzed using Western
blot and the Bio-PlexH protein array (BPA) technology. Additional histological severity for fibrosis, inflammation, vascularity
and cellularity alterations scoring was defined from histology and immnunohistochemistry analyses.
Results: A significant increase of histological severity scoring was found in irradiated tissue. Skin tissues were more radio-
sensitive than muscle. A high level of TGF-b1 expression was found throughout the study and a significant relation was
evidenced between TGF-b1 expression and fibrosis scoring. Irradiated tissue showed a chronic inflammation (IL-2 and TNF-a
significantly increased). Moreover a persistent expression of GM-CSF and VEGF was found in all irradiated tissues. The
vascular score was related to TGF-b1 expression and the cellular alterations score was significantly related with the level of
IL-2, VEGF and GM-CSF.
Conclusion: The results achieved in the present study underline the complexity and multiplicity of radio-induced alterations
of cytokine network. It offers many perspectives of development, for the comprehension of the mechanisms of late injuries
or for the histological and molecular evaluation of the mode of action and the efficacy of rehabilitation techniques.
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Introduction
Radiotherapy is an integral part of overall cancer therapy and
nearly two thirds of all cancer patients have received radiotherapy
at some point during their disease management [1,2]. Its efficacy is
still limited by the tolerance of healthy tissue included in the target
volume of irradiation and by its side effects. Understanding the
mechanisms of radiation-induced tissue degeneration is therefore
essential to improve the tolerance of healthy tissues to radiation
and to develop methods of tissue rehabilitation.
Histologically, the four main phenomena involved in late effects
development appear to be inflammation, fibrosis, vascular alter-
ations and cellular depletion [3,4,5,6]. The involvement of each of
these phenomena in the genesis of late effects is highly debated.
After radiotherapy, two types of deterministic effects are
classically distinguished depending on their time of occurrence:
early effects and late effects. This is based on clinical and on
physiopathological concepts: early effects are easily predictable
and occur soon after irradiation. Late effects can appear clinically
months, even years after exposure to ionizing radiation [7,8].
Nevertheless, it should be noted that the distinction between acute
and late effects is arbitrary because it is actually a continuum [3,4].
Late effects are the consequences of an imperfect tissue remodeling
and of persistent radiation induced injuries. However, the
molecular mechanisms involved in the development of these
effects remain unclear. Chronic radio-induced toxicity may be
induced by dysregulation of many mediators including perpetual
cascades of cytokines [4,5,7,9,10]. In the current physiopatholog-
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a key role [11]. It perpetuates cellular damages, so that normal
tissue regeneration is impossible. However, most of the studies
were focused on lungs [12,13,14], and the precise role of hypoxia
in other tissues is still unclear.
Indeed most clinical prospective studies assay growth factors
and interleukins on serum in order to predict symptomatic radio-
induced lung injury [15,16,17,18,19].
Within tissues, intercellular communication pathways are
complex and include autocrine and paracrine mechanisms.
Therefore, the resulting effect depends on the local balance
between different types of mediators whose regulation and spatio-
temporal distribution are crucial [20,21]. The balance cannot be
understood without studying the local equilibrium. Consequently,
the development of animal model of radio-induced injury is a
necessity. Some studies have investigated the tissue concentrations
of cytokines and interleukins, mainly in lungs [12,13,14,22], gut
[23,24], or brain [25] but studies on skin and muscle are rare. In
addition, all these studies are focused on one or at most 3
mediators [13,14,22,23,24,25,26].
The aim of this study was to analyze the variations of the main
mediators of the four cytokine and growth factor families involved
in inter-cellular exchanges during radiation-induced tissue degen-
eration in skin and muscles. An animal model of radiation-induced
tissue degeneration was used for this purpose [27]. The expression
of proinflammatory (IL-1a, IL-2, IL-6, TNF-a, IFN-c), profibrotic
(TGF-b1), proangiogenic (VEGF) and stem cell mobilizing (GM-
CSF) cytokines (Figure 1) was analyzed using Western blot and the
Bio-PlexH protein array (BPA) technology. Additional histology
and immnunochemistry studies were performed.
Materials and Methods
Ethics Statement
The experimental protocol was conducted in accordance with
the regulations of our local ethics committee (The Ethics
Committee of Nancy Lorraine-France, approval authorization
number: C54-547-5) and with the Animal Welfare Act of the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH Publication no. 85-23, Revised 1996).
Animals
This 12-month study was conducted using 24 adult male Wistar
rats (Janvier CERJ, Le Genest Saint Isle, France) with an initial
body weight of 420–460 g. The rats were maintained in a specific
environment with controlled temperature and humidity and an
automatically regulated 12-h light/dark cycle, and were fed a
standard commercial diet and given water ad libitum.
General experimental design
Under general anesthesia, the animals (3 groups of 8 rats) were
administered a single dose of 30 Gy unilaterally on the hindlimb.
The first group was euthanized 6 weeks, the second six months
and the third one year after irradiation. Immediately before
sacrifice, tissue samples of skin and muscle were collected on each
hindlimb in order to process BPA assay and western blot. The
remaining tissues were removed and fixed for histological and
immunohistochemical analysis. Unirradiated hindlimbs were used
as controls.
Irradiation procedures
Cobalt 60 irradiation was chosen to minimize the difference
between the absorbed dose in soft and hard tissues. Prior to
irradiation, a scanner acquisition (Philips Brillance 40) enabled the
calculation of dosimetry (Isogray 3.0 software Dosisoft). Irradiation
of the hindlimb was performed under general anesthesia as
described previously (21). Briefly, the animals were placed in a
prone position upon a thick polystyrene phantom. The hindlimbs
were additionally immobilized by adhesive tape. The skin distance
focus was 70 cm, and the field size was 20x30 cm. The lead
collimating block was positioned on a 0.5-cm thick acrylic platform
to shield the body, allowing exposure of only the hindlimb without
the pelvis. Radiation was delivered in a vertical beam from a
TheratronH 780CX-ray machine delivering c-rays of 1.25 MeVe-
nergy. The irradiated volume was 40 cm3 at a dose rate of 1.4 Gy/
min. The room temperature during irradiation was 22uC.
Histopathological and immunochemistry studies
Gastrocnemius muscle and skin were removed and fixed in AFA
(acid acetic,formaldehydeand alcohol).Eachsample was embedded
in paraffin, cut into 5-mm sections and stained prior to light
microscopic observation: hematoxylin eosin, sirius red and FVIII
immunohistochemistry (polyclonal rabbit, 1:400, Dako Corpora-
tion, Trappes, France) were performed on Ventana Benchmark.
All microscope images (microscope Aristopla, LeicaH), were
captured with a camera (Olympus DP Controler, Olympus
Optical) and analyzed with image analyzing software (TRIBVN-
ics image communication software version 1.5, Chantillon France).
Assessment of the severity of lesions
Histopahological analyses were performed in skin and muscles
specimens taken from irradiated and control unirradiated
hindlimb. The four following parameters were studied: fibrosis,
inflammatory infiltrates, vascular alterations, cellular depletions
and alterations. For each parameter, a score of severity was
established, from 0 (no alteration) to 3 (severe alterations), using
the visual scale presented here (Figure 2).
Each captured image was blindly analyzed twice at three weeks
interval by two independent observers. Intra and inter observer
reliability of the classification was verified by the concordance with
Figure 1. Simplified model of the complex network of
interacting processes and signals in the pathogenesis of
radio-induced injury. The main mediators of the four cytokine and
growth factor families involved in inter-cellular exchanges during
radiation-induced tissue degeneration in skin and muscles are.repre-
sented, namely the expression of proinflammatory (IL-1a, IL-2, IL-6, TNF-
a, IFN-c), profibrotic (TGF-b1), proangiogenic (VEGF) and stem cell
mobilizing (GM-CSF) mediators.
doi:10.1371/journal.pone.0029399.g001
Mediators Expression in Irradiated Tissues
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Protein extraction
Protein from tissue specimens were extracted by using a cell
lysing kit (Bio-Rad) according to the manufacturer’s recommen-
dations. The specimens were disrupted using a steel-bead tissue
lyser (Tissuelyser, Qiagen) for 3 min at 30 cycles per sec. Protein
concentration in supernatants was determined using the BioRad
Dc Protein assay according to the manufacturer’s recommenda-
tions. Then, the proteins extracts were stored frozen at 280uC
until analyzed.
BPA assay
Multiplex sandwich bead immunoassays were used to analyze
the expression of the cellular mediators. All experiments were
carried out in triplicate. Protein concentration was determined as
indicated above, adjusted to 1 mg/ml of total protein. Protein
extracts were transferred into 96-well dishes and diluted with
buffered solution (Lincoplex assay buffer). Fluorescent capturing
beads coupled to antibodies directed against IL-1a, IL-2, IL-6, IL-
10, TNF-a, IFN-c, VEGF and GMCSF (Linco Research (R-
CYTO-80K-08)) were mixed. The antibody-conjugated beads
were added into each well and incubated for 12 h at 4uC. The
plates were washed (Lincoplex wash buffer) and incubated (1h at
21uC) with biotinylated antibodies to fix each target protein. The
plates were then washed and Streptavidin–phycoerythrin solution
was then added (30 min at 21uC).
Results were recorded as mean fluorescence intensities and
normalized to the data measured in the positive controls.
Non-irradiated limbs were used as controls and all data were
analyzed respectively to control at the same time. Skin and
muscles were analyzed independently.
Western blot analysis
Protein concentration was determined as indicated above,
adjusted a concentration of 12 mg/ml of total protein. Dilution was
performed with buffer Laemmli (Bio-RadH). TGF-b1 activation
was performed by heating the specimen at 80uC for 5 min. The
proteins were electrophoresed at 100 V for 120 min (PowerPac
200, Bio-Rad) in SDS-polyacrylamide gel (10%) and then
transferred onto a polyvinylidene difluoride membrane (Hybon-
P–GE Healthcare AmershamH ) at 80 mA for 30 min by use of a
Transblot SD 5Bio-Rad). Nonspecific binding was blocked with
5% milk for 1 h at room temperature. Immunodetection of the
proteins was performed with specific primary antibody (TGF-b
dilution range 1/500 sc-52893, Santa Cruz Biotechnology) in
TBST 0.1% with 5% milk and incubated overnight at 4uC. The
membranes were washed and incubated with mouse peroxydase-
secondary anti-IgG1 (dilution range 1/2000) for 1 h and washed.
Immunoreactive proteins were visualized by using electrolumines-
cent reagent (Kit ECL Western blotting Detection reagents–GE
Healthcare Amersham H).
Each dried blot was numerized at 100 dpi (Perfection 1670
scanner; Epson) and processed using ImageJ, Java-based image
processing software (Rasband WS; NIH).
The area of the peak was determined and compared to that of a
reference sample of known concentration in TGF-b1. Values were
expressed as percentage of control.
Non-irradiated limbs were used as controls and all data were
analyzed respectively to control at the same time. Skin and
muscles were analyzed independently.
Comparison of histopathological and immunochemistry
studies with BPA assays and western blot
For each severity score of fibrosis, inflammation, vascular
alterations, cellular depletions and alterations were reported to
corresponding levels of mediators expression.
Statistical analysis
The statistical significance of differences between the groups was
determined using the Student’s t-test. For each score of severity,
the correlations between the score and the level of expression of
each mediator were determined. p,0.05 was considered as
significant.
Results
Histopathological results
Irradiation at a monodose of 30 Gy induced in all irradiated
tissue a marked increase of histological scoring compared to
unirradiated hindlimb. However, no significant differences could
be found over time (Figure 3).
An increase in fibrosis score was observed 1 year after
irradiation, in both skin and muscle. In skin, the inflammation
score appeared to decrease at 6 months, but increased at 1 year.
However, in the muscle, the inflammation score increased with
time.
Inter-observer reproducibility was good for all the parameters of
the histological classification (Kappa value are listed Table 1).
Expression of cytokines and growth factors
Cytokine expression in irradiated skin. During this study,
the control values obtained from the unirradiated contralateral
hindlimb were stable over time. The results are shown in Figure 4.
All pro-inflammatory mediators (IL-1a, TNF-a, IL-2, IFN-c,
IL-6) evolved consistently with time. Six weeks after irradiation,
TNF-a was significantly higher than control (+66%, p=0.009) as
well as IL-2 (+458%; p=0.013). The expression level of IFN-c also
tended to rise. Six months after irradiation, the inflammatory
reaction tended to attenuate: IL2 remained moderately elevated
(+83%, p=0.028) but the increase of TNF-a was no longer
significant (+22%, p=0.231) while IFN-c and IL-1a decreased
markedly (respectively 234%, p=0.035 and 242%, p=0.015).
However, one year after irradiation, there was a small intensifi-
cation of inflammatory reaction, with a significant increase of
TNF-a (+53%, p=0.002), and IL-2 (+350%, p=0.006). At one
year, the expression level of IL-1 was also found to be increased
but did not reach statistical significance. During the study, the
difference in the expression of IL-6 and IL-10 between irradiated
hindlimbs and non irradiated hindlimbs never reached statistical
Figure 2. Scale of severity for inflammation, fibrosis, vascularity and cellular alterations. The inflammation score, evaluated on
hematoxylin eosin-stained slides, was based on the presence of inflammatory infiltrates. The fibrosis score evaluated on sirius red-stained slides,
depend on the intensity of the fibrosis and the modification of the tissular structure. The vascular score was evaluated both on sirius red- and FVIII-
stained slides. It was calculated from the number and the alterations of structure of vessels. The cellular alterations score was evaluated on
hematoxylin eosin-stained slides. In skin, it was calculated according to the loss and necrosis of cells as well as the number of myofibroblasts. In
muscles, it depends mainly on the presence of dystrophic nuclei and necrosis.
doi:10.1371/journal.pone.0029399.g002
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cytokines (IL-1a, TNF-a, IL-2, IFN-c, IL-6) measured at 6 weeks
appeared to decrease at 6 months, then the trend reversed at 1
year.
Positive correlations were found between TNF-a and IL-1a
(r=0.690, p,0.001), IL-2 and TNF-a (r=0.558, p,0.001) and
IFN-c and IL-1a (r=0.429 p,0.001). As expected, the anti-
inflammatory mediator IL-10 was negatively correlated to TNF-a
(r=20.324, p=0.001) and IL-1a (r=20.182, p=0.05).
The expression of the profibrotic mediator TGF-b remained
markedly increased during the study. Six weeks after irradiation,
the level of TGF-b was 2.2 times (p=0.001) higher than that
measured on unirradiated tissue and reached 2.7 times (p=0.013)
6 months after irradiation. At one year, the level of TGF-b was still
significantly increased but to a lesser extent (+65%, p=0.017).
The TGF-b was negatively correlated to IL-10 (r=20.252,
p=0.014).
Six weeks after irradiation, the expression level of the pro-
angiogenic mediator VEGF was markedly increased (+177%,
p=0.05). This increase persisted over time and VEGF expression
doubled (+119%, p=0.181) 6 months after irradiation and
reached four times the controlateral unirradiated level (+323%;
p=0.233) after one year. However the values did not reach
statistical significance, probably due to the small number of
sample. The pattern of VEGF expression, with a slight decrease at
6 months and an increase at one year, was similar to the pattern of
Figure 3. Evolution of the score of fibrosis, inflammation, vascularity and cellular alterations with time in skin and muscle. The
fibrosis score showed an increased with time in both skin and muscle. In skin, the inflammation score appeared to decrease at 6 months, but
increased at 1 year. In muscle, the inflammation score increased consistently with time.
doi:10.1371/journal.pone.0029399.g003
Table 1. Intra- and inter- observer reproducibility of the histological scoring in skin and muscle. All figures are mean Kappa values
+/2 standard deviations.
Intra-observers reproducibility Inter-observers reproducibility
AB
Skin
Fibrosis score 0.78+/20.09 0.73+/20.1 0.69+/20.1
Inflammation score 0.82+/20.08 0.76+/20.09 0.77+/20.09
Vascular score 0.41+/20.11 0.69+/20.1 0.77+/20.09
Hypocellularity score 0.78+/20.09 0.77+/20.09 0.73+/20.09
Muscle
Fibrosis score 0.44+/20.16 0.59+/20.12 0.67+/20.12
Inflammation score 0.54+/20.14 0.65+/20.14 0.86+/20.12
Vascular score 0.77+/20.14 0.47+/20.14 0.82+/20.11
Hypocellularity score 0.62+/20.14 0.47+/20.14 0.76+/20.16
doi:10.1371/journal.pone.0029399.t001
Mediators Expression in Irradiated Tissues
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29399expression of pro-inflammatory cytokines. A positive correlation
was observed between VEGF and IL-2 (r=0.585; p,0.001) and
between VEGF and GM-CSF (r=0.689; p,0.001).
Six weeks after irradiation, the expression of the stem cell
mobilizing cytokine GM-CSF was higher than control (x33.6;
p=0.047). This increase persisted over time with an increase of
2.5 times (p=0.022) and 5.5 times (p=0.048) respectively 6
months and one year after irradiation. As for VEGF, the profile of
evolution was similar to the inflammatory reaction and IL-2 was
positively correlated with GM-CSF (r=0.744, p,0.001).
Cytokine expression in irradiated muscle. Differences
between irradiated and non irradiated samples of muscles were less
marked and most of the results were not significant.
The evolution of the mediators was slightly different from that
found in the skin. The inflammatory reaction seemed initially less
intense, then appeared gradually, with a progressive trend to
increase of IL-1, TNF-a, and IL-2, which was not statistically
significant.
The level of TGF-b increased later than in the skin, but the
differences between irradiated and non irradiated samples were
very marked at 6 months (more than 10 fold increase, p=0.017)
and at 1 year (3 fold increase, p=0.041). The profile of variation
in the expression of GM-CSF and VEGF seemed to be similar to
that of the inflammatory reaction.
Relations between histopathological results and
expression of mediators
The significant variation of expression of cytokine or growth
factor for each score of severity from inflammation, fibrosis,
vascularity and cellular alterations are shown in Figure 5.
In skin, the global profile of evolution in time was similar for pro-
inflammatory cytokines and for histological scores, always with a late
intensification. Higher scores of inflammation were associated with
higher levels of IL-2 (r=0.274, p=0.05), TGF-b1 (r=0.484,
p=0.001) and GM-CSF (r=0.358, p=0.002). The impact of the
variation of TNF-a on the inflammation score was moderate (r=0.3,
p=0.05). On the contrary, IL-1 levels significantly decreased with
increase of the inflammation score (r=20.4, p=0.008).
A significant relation was found between TGF-b1 expression and
histological fibrosis scoring (r=0.554, p=0.002). The fibrosis score
also increased with the level of IL-2 (0.453, p=0.003), and with TNF-
a (r=0.497, p=0.001). No relation could be found between the levels
of expression of the other pro-and anti-inflammatory mediators (IL-1,
IL-6, IL-10) and the fibrosis score (data not shown), the expression
levels of GM-CSF and VEGF both increased with the severity of
fibrosis(r=0.455,p=0.002andr=0.342,p=0.027respectively).
The levels of expression of the key mediators were not related
with vascular score, except for TGF-b1 (r=0.521, p,0.001),
Figure 4. Mean differences of expression of different mediators between healthy skin and irritated skin over time. All pro-
inflammatory mediators (IL-1a, TNF-a, IL-2, IFN-c, IL-6), the pro-angiogenic mediator VEGF, and the stem cell-mobilizing cytokine GM-CSF evolved
consistently with time, the level of expression measured at 6 weeks appeared to decrease at 6 months, then the trend reversed at 1 year. The
expression of the profibrotic mediator TGF-b remained markedly increased during the study. (*: p,0.05 and **: p,0.01)
doi:10.1371/journal.pone.0029399.g004
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and cellular alterations in skin and muscles. In skin only significant variations are shown. The y-axis corresponds to the level of expression of
each cytokine in ng/mg of total protein.
doi:10.1371/journal.pone.0029399.g005
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and at a lower level for VEGF and GM-CSF which increased with
mild alterations (p,0.05).
The cellular alterations score was significantly related with the
level of IL-2 (r=0.3, p=0.05), VEGF (for mild alterations,
p,0.05), GM-CSF (r=0.37, p=0.017) and TNF-a (r=0.5,
p=0.001). Finally, the level of IL-1 expression slightly decreased
when the cellular alterations score increased (r=20.37, p=0.02).
In muscles, the major significant relation was found between
TGF-b1 expression and histological scoring with a late intensifi-
cation (r=0.67, p,0.001).
Discussion
Radiotherapy-induced late normal tissue injury within the
irradiated field is a significant cause of morbidity and decrease
quality of life in cancer patients [28]. This justifies the evaluation
of biomarkers predictive of late toxicity of radiation. The present
study was performed in a model of late tissue radio-induced
degeneration [27], enabling the assessment of histological changes
and dysregulation of molecular mediators in irradiated tissues.
Despite monodose irradiation, the histological and macroscopic
modifications observed in this study were very similar to those
observed after radiotherapy in humans. In our model, inflamma-
tion was maximal at 30 days, followed by fibrosis starting at 6
weeks, stabilizing at 3 months but sometimes continuing through
successive stages. However, the main problem with the histological
analysis of irradiated tissues is that radiation-induced injuries are
focal so that analysis might miss some aspects of radiation-induced
degeneration. This is the reason why we developed a histological
scoring system and tested its reliability prior to analysis. Intra-and
inter-observers reliabilities were good, but it clearly appeared to us
that histological analysis was not sufficient for precisely evaluating
radio-induced tissular degeneration. In this context, the analysis of
cytokine and mediator expression appeared to be an attractive
method of evaluation of tissular changes after irradiation.
Very often, the analysis of expression of cytokines and growth
factors is based on immunochemistry [12,25,26,29] or mRNA
expression analyses [23,25,26,30]. This gives an insight into the
production of proteins, but without quantifying their real
concentration in the tissue, which is determinant for the actions
of the mediators studied. In this study, the methodology was based
on the direct analysis of protein using the Bio-PlexH cytokine
array. Indeed, the determined levels of expression of the key
mediators in this study were coherent, and the expected
correlations between pro- and anti-inflammatory mediators could
be identified. This confirms the reliability of the methodology.
Expression levels of the key mediators studied were consistent
with the current model of radio-induced tissular degeneration.
Similarly to other works [14,30,31,32], particularly in the skin, a
high level of TGF-b1 was found throughout the study. TGF-b1i s
known to control the regulation and inhibition of cell growth and
the homeostasis of the extracellular matrix. Dysregulation of TGF-
b1 is involved in the development of fibroproliferative diseases
[33,34,35]. The increased expression of TGF-b1 was already
present 6 weeks after irradiation, so that the initiation of this
process was certainly earlier. Indeed, several authors found an
induction of TGF-b1 during the first 24 hours after irradiation
[36,37,38]. In this study, a significant relation was found between
TGF-b1 expression and histological scoring. These results
highlight the crucial role of this cytokine in the pathogenesis of
radiation fibrosis.
The precise role of inflammation in the constitution of late
injuries is less clear. Similarly to others studies, a chronic release of
proinflammatory mediators was observed in irradiated tissues in
our model. The TNF-a levels of expression were increased during
all the observation period. This was consistent with other studies
reporting that in the lungs, an increase of TNF-a expression was
detected during the first 10 days after irradiation [13] and that
values of TNF-a mRNA remained elevated 25 weeks after
irradiation [23]. IL-2 levels were also elevated during all the
study, with the same profile of evolution. On the contrary, IL-1a
increased only later in our model. This could be surprising, as in
vitro and in vivo studies highlighted that thoracic irradiation
induced prolonged release of IL-1a in serum and in lung samples
[30,39,40]. But Rube et al. already found in irradiated lung
samples that after an initial increase of IL-1 during the first hours
after irradiation, IL-1 returned to a baseline threshold and
elevated markedly only after 8 and 16 weeks. In the present rat
model, 6 weeks might correspond to the period of baseline
threshold of Rube et al. study [38]. In fact, histological findings
and scores were similar to these molecular changes: following an
initial inflammatory phase, there was a decrease in inflammation
at 6 months and then a rebound of inflammatory reaction was
found at 1 year. This late intensification of inflammatory reaction
was particularly marked with a very significant increase of the IL-
1a expression between 6 and 12 months (p=0.007). Similar late
intensification was also observed for muscles in our model.
Chronic inflammatory reaction is usually considered as the
trigger for radiation-induced fibrosis and some authors proposed
that pro- and anti-inflammatory cytokines might be used as
markers for predicting late injuries: Chen and coworkers [18]
found that elevated pre-irradiation levels in IL-1a and IL-6 were
predictive of radiation-induced symptomatic pneumopathy. Sim-
ilarly, Arpin and coworkers [17] found that high levels of IL-10
were protective against radiation induced symptomatic pulmonary
fibrosis after thoracic radiotherapy, while elevation of IL-6 was
associated with more severe lesions. This might be explained by
the known direct antagonism between IL-10 and TGF-b1, and by
the inhibition of the production of IL-10 by TGF-b1 associated
with IL-6 in the T-reg pathway [41]. Nevertheless, the precise role
of these cytokines in the constitution of late lesions remains
controversial and some studies were in contradiction with Chen’s
and Arpin’s results. Barthelemy-Brichant and coworkers [42]
found no relation between IL-6 and radiation pneumonitis and a
multicytokine analysis of plasma of patients showed that only low
pre-treatment levels of IL-8 were predictive of radiation
pneumonitis. Our model confirms that IL-10 might play a
protective role against fibrosis, as elevation of IL-10 was slightly
related with lower levels of TGF-b (r=20.25, p=0.02), but this
role is not confirmed by histological scores. Similarly, the increase
of IL-1a expression was not associated with more severe lesions
(fibrosis, inflammation, vascular alterations and cellular alterations
scores). Finally, the relation between levels of expression of TNF-a,
and the fibrosis, the inflammation or the vascular alterations scores
was only moderate in our model. On the contrary, the
inflammation, cellular alterations and fibrosis scores were related
to variations of IL-2. Consequently, IL-2 appeared to play a
crucial role in the constitution of late injuries in our model. The
radio-induced injuries might be preferentially Th1-mediated.
Further investigations of the immune balance would clarified the
impaired interactions between Th1/Th2/Th17/Treg.
Recently, hypoxia has been placed in the center of all the
models of radio-induced tissular degeneration. All authors agree
on the fact that irradiation has deleterious effects on vasculariza-
tion and neoangiogenesis [43,44,45]. VEGF is the main
proangiogenic molecule and probably the most studied. Ebrahi-
mian et al.[46] showed that irradiation hampered skin perfusion,
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studies [12,14,25,26], we observed an increase of VEGF and this
throughout the study. VEGF usually promotes revascularization
and wound healing [47,48], but despite an increase of this
angiogenic signal, histological and immunochemistral studies
demonstrated typical decreased vascularity and alterations of the
vascular wall [44,45,49]. Indeed, VEGF is known to be able to
affect vessel permeability. It has been shown to induce fenestra-
tions in capillary endothelial cells [50] and to affect occludin
expression and tight junction assembly [51]. In our study,
immunochemistry revealed diffuse expression of FVIII in
irradiated tissues. As in the irradiated spinal cord [25], we can
hypothesize that VEGF contributed to increase the vascular
permeability in irradiated tissue and to perpetuate the vascular
impairment.
Though we found no major relation between VEGF levels and
the fibrosis score (r=0.34, p=0.027), the increase of VEGF we
observed was more moderate than in other studies [12,14]. This
difference with existing studies might be explained by the type of
tissue studied. Indeed, most of the existing studies were conducted
in lung tissues, which have a particular vascularity system and
hypoxia could also be the consequence of the impaired pulmonary
function. The landmark of hypoxia HIF-1 is the upstream cytokine
of VEGF, consequently further investigations may be necessary to
link hypoxia, VEGF, vascular damage and late radiation-induced
injuries in skin and muscle.
In our model, a persistent high level of GM-CSF, a cytokine
with a specific ability to mobilize stem cells, was found throughout
the time of the study in irradiated skin and muscle. In skin, GM-
CSF appeared correlated to fibrosis score (r=0.455, p=0.002)
and hypocellularity score (r=0.37, p=0.017). An increase in GM-
CS had already been highlighted in irradiated lung tissue, but
during the early response to radiation (,10 days) [13]. However,
this increase could not be detected in serum samples after lung
irradiation neither in mice [13] nor in patients [19]. As the GM-
CSF level of expression was high throughout this study, it may be
hypothesized that irradiated tissues try to mobilize and recruit
stem cells in order to overcome the hypoxic and scarring problem
[23,52,53,54,55]. The presence of stem cells in irradiated tissues
might help scarring of wounded tissues [52,53,56]. It has been
shown that injection of the growth factors G-CSF, SCF and/or
GM-CSF could be used to improve radioprotection or radio-
induced tissue injury [20,23]. However, these treatments have a
saturating effect [20], probably due to the limited capacity of
effective recruitment of stem cells. In our model, despite the
increase of GM-CSF within the irradiated tissue, histological
studies showed persistent hypocellularity. The number of stem
cells reaching and/or integrated in these tissues appears to be
insufficient. The radio-induced alteration of blood vessel walls
[45,49,57] and fibrosis [4,9] probably limit the extravasation of
stem cells. Consequently, stem cell therapy might provide a means
to reduce radiation-induced side effects [28]. Local injection of
stem cells could bring multipotent functional cells, able to replace
the differentiated cells, interact with the environment through
secretion of biofactors, and regulate the inflammatory microenvi-
ronment, while inducing and participating in neoangiogenesis.
Conclusion
Our animal model of radio-induced tissular degeneration
appeared to be reliable and showed a good coherence with the
existing theories of the physiopathology of radio-induced degen-
eration. It offers many perspectives for development, for the
comprehension of the mecanisms of late injuries, and for the
histological and molecular evaluation of the mode of action and
the efficacy of rehabilitation techniques.
The results achieved in the present study underline the
complexity and multiplicity of radio-induced alterations of
cytokine networks. In this context, the results achieved suggest
that stem cell therapy might represent an interesting approach to
overcome radiation-induced injuries, in relation with the extensive
paracrine activity of stem cells.
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